title: Neutrophilic eccrine hidradenitis secondary to topotecan.
abstract: BACKGROUND
  Neutrophilic eccrine hidradenitis (NEH) is a self-restricted inflammatory condition, usually secondary to chemotherapeutic agents and less frequently to other drugs such as zidovudine or various infections. NEH clinical features include erythematous, occasionally painful nodules and plaques. Histological examinations reveal neutrophilic infiltrates and degeneration of eccrine glands.
  
  
  METHODS
  A 45-year-old female was treated with topotecan and colony-stimulating factor for ovarian cancer.
  
  
  RESULTS
  The erythematous and slightly pruritic plaques on the upper and lower limbs and ear lobes appeared approximately 1 week after chemotherapy and spontaneously subsided in about 10 days, only to recur after the next drug dose. A skin biopsy revealed NEH; all skin cultures were negative.
  
  
  CONCLUSIONS
  It is believed that this patient developed topotecan-induced NEH; this relationship with therapy rather than the underlying disease rules out a paraneoplastic reaction, and negative cultures excluded infectious causes. In addition, since skin lesions recurred after CSF was discontinued, this agent was not involved. Studies relating NEH to topotecan, a topoisomerasa I inhibitor, have not reported such an event in the literature.
authors: Department of Dermatology, Hospital de Clínicas, University of Buenos Aires School of Medicine, Buenos Aires, Argentina. mamarini@infovia.com.ar
authors: M
authors: M
authors: Marini
authors: D
authors: D
authors: Wright
authors: M
authors: M
authors: Ropolo
authors: M
authors: M
authors: Abbruzzese
authors: G
authors: G
authors: Casas
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D016575:Hidradenitis / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008875:Middle Aged; D019772:Topotecan / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D019772:Topotecan